14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.90 $2.14 Friday, 3rd May 2024 FGEN stock ended at $1.14. This is 0.88% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 9.43% from a day low at $1.12 to a day high of $1.22.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Oct 01, 2021 $10.21 $10.40 $10.12 $10.34 1 003 713
Sep 30, 2021 $10.34 $10.49 $10.20 $10.22 601 616
Sep 29, 2021 $10.48 $10.66 $10.27 $10.31 674 666
Sep 28, 2021 $10.80 $10.87 $10.39 $10.42 898 968
Sep 27, 2021 $10.81 $10.95 $10.62 $10.81 948 467
Sep 24, 2021 $10.69 $10.90 $10.60 $10.80 806 725
Sep 23, 2021 $10.19 $10.74 $10.19 $10.74 926 144
Sep 22, 2021 $10.82 $10.85 $9.89 $10.18 3 268 541
Sep 21, 2021 $11.37 $11.52 $11.18 $11.24 702 485
Sep 20, 2021 $11.37 $11.51 $11.08 $11.27 1 061 201
Sep 17, 2021 $11.74 $11.85 $11.43 $11.69 4 330 087
Sep 16, 2021 $11.60 $11.76 $11.34 $11.72 1 013 737
Sep 15, 2021 $11.54 $11.87 $11.40 $11.70 997 556
Sep 14, 2021 $11.72 $11.97 $11.46 $11.53 998 896
Sep 13, 2021 $11.37 $12.06 $11.32 $11.73 1 188 300
Sep 10, 2021 $11.79 $11.86 $11.27 $11.34 1 109 728
Sep 09, 2021 $12.05 $12.17 $11.74 $11.79 1 052 574
Sep 08, 2021 $12.31 $12.40 $11.95 $12.00 1 088 561
Sep 07, 2021 $12.43 $12.65 $12.10 $12.41 911 895
Sep 03, 2021 $12.47 $12.65 $12.18 $12.40 934 120
Sep 02, 2021 $12.34 $12.52 $11.98 $12.50 1 447 693
Sep 01, 2021 $11.74 $12.66 $11.73 $12.39 2 137 018
Aug 31, 2021 $11.70 $12.08 $11.55 $11.63 2 133 369
Aug 30, 2021 $11.68 $11.83 $11.37 $11.50 864 348
Aug 27, 2021 $11.44 $11.65 $11.14 $11.55 1 704 734
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT